Life Sciences: Regulatory/Compliance

Peter Handrinos is noted for his representation of investment banks and public companies in life sciences-related capital markets transactions and securities-related matters.

"Peter is tremendously responsive and has vast breadth of experience."

Cheston Larson advises biotech and other life sciences companies through all stages of their life cycle. His practice focuses on corporate and financing transactions. His work covers venture financing, IPOs, and M&A transactions.

Jennifer Bragg offers significant experience handling complex, high-stakes FDA enforcement matters. She regularly advises clients on internal and external investigations and conducts due diligence for major pharmaceutical companies.

John Manthei advises pharmaceuticals, biotechnology and medical device companies on all manner of FDA and other regulatory procedures governing the life sciences sector. His expertise includes the negotiation of clinical trial agreements, pre-market product development and the regulation of marketing materials.

"John always gives us the right guidance and has helped us through some really thorny issues. He's such an expert at FDA regulations."

Michael Morin is known for his extensive representations of large pharmaceutical companies in connection to patent and copyright infringement matters.

"Mike is truly an exceptional trial lawyer. He's one of the best cross examiners I have seen and has a great rapport with the judges. He's someone you can trust in bet-the-company litigation."